Effect of the staging of rhino-orbital-cerebral mucormycosis on its management and clinical outcome.
作者信息
Raj Anuradha, Gupta Vikas, Krishnamoorthi Sivanantham, Kaur Harmeet, Saini Vaibhav
机构信息
Department of Ophthalmology, All India Institute of Medical Sciences, Bathinda, Punjab, India.
Department of Otorhinolaryngology, All India Institute of Medical Sciences, Bathinda, Punjab, India.
出版信息
Indian J Ophthalmol. 2024 Oct 1;72(10):1519-1523. doi: 10.4103/IJO.IJO_2799_23. Epub 2024 Sep 27.
Abstract
摘要
相似文献
1
Effect of the staging of rhino-orbital-cerebral mucormycosis on its management and clinical outcome.
Indian J Ophthalmol. 2024 Oct 1;72(10):1519-1523. doi: 10.4103/IJO.IJO_2799_23. Epub 2024 Sep 27.
2
Bilateral Rhino-Orbital-Cerebral Mucormycosis.
JAMA Ophthalmol. 2024 Jul 1;142(7):e236486. doi: 10.1001/jamaophthalmol.2023.6486. Epub 2024 Jul 18.
3
Rhino-orbital mucormycosis and aspergillosis: differences in outcome, clinical and imaging characteristics.
Eur Arch Otorhinolaryngol. 2010 Jan;267(1):161-2. doi: 10.1007/s00405-009-1136-z. Epub 2009 Nov 5.
4
Orbital exenteration: A dilemma in mucormycosis presented with orbital apex syndrome.
Am J Rhinol. 2008 Jan-Feb;22(1):98-103. doi: 10.2500/ajr.2008.22.3121.
5
Rhino-orbital-cerebral mucormycosis. A retrospective analysis and treatment option.
Indian J Ophthalmol. 2004 Mar;52(1):82; author reply 82-3.
6
[Rhino-orbito-cerebral mucormycosis].
Tunis Med. 2013 Feb;91(2):164-5.
7
Rhinocerebral mucormycosis with perineural spread.
Ophthalmic Plast Reconstr Surg. 2007 Jul-Aug;23(4):326-7. doi: 10.1097/IOP.0b013e318070855b.
8
Rhino-orbito-cerebral mucormycosis.
Braz J Otorhinolaryngol. 2009 Jul-Aug;75(4):619. doi: 10.1016/s1808-8694(15)30505-x.
9
Successful treatment of rhino-orbital mucormycosis without exenteration: the use of multiple treatment modalities.
Ophthalmic Plast Reconstr Surg. 2001 Jan;17(1):62-6. doi: 10.1097/00002341-200101000-00012.
10
Liver cirrhosis and rhino-orbital mucormycosis, a possible but rare association: description of a clinical case and literature review.
Braz J Infect Dis. 2009 Aug;13(4):314-6. doi: 10.1590/s1413-86702009000400015.
本文引用的文献
1
Hyperglycemia and steroid use increase the risk of rhino-orbito-cerebral mucormycosis regardless of COVID-19 hospitalization: Case-control study, India.
PLoS One. 2022 Aug 8;17(8):e0272042. doi: 10.1371/journal.pone.0272042. eCollection 2022.
2
COVID-19-associated mucormycosis presenting to the Emergency Department-an observational study of 70 patients.
QJM. 2021 Nov 5;114(7):464-470. doi: 10.1093/qjmed/hcab190.
3
Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India.
Diabetes Metab Syndr. 2021 Jul-Aug;15(4):102146. doi: 10.1016/j.dsx.2021.05.019. Epub 2021 May 21.
4
Rise of the phoenix: Mucormycosis in COVID-19 times.
Indian J Ophthalmol. 2021 Jun;69(6):1563-1568. doi: 10.4103/ijo.IJO_310_21.
5
Code Mucor: Guidelines for the Diagnosis, Staging and Management of Rhino-Orbito-Cerebral Mucormycosis in the Setting of COVID-19.
Indian J Ophthalmol. 2021 Jun;69(6):1361-1365. doi: 10.4103/ijo.IJO_1165_21.
6
Corticosteroids for treating mild COVID-19: opening the floodgates of therapeutic misadventure.
QJM. 2021 Nov 5;114(8):541-542. doi: 10.1093/qjmed/hcab138.
7
Mucor in a Viral Land: A Tale of Two Pathogens.
Indian J Ophthalmol. 2021 Feb;69(2):244-252. doi: 10.4103/ijo.IJO_3774_20.
8
Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium.
Lancet Infect Dis. 2019 Dec;19(12):e405-e421. doi: 10.1016/S1473-3099(19)30312-3. Epub 2019 Nov 5.
9
Mucormycosis in Iran: A six-year retrospective experience.
J Mycol Med. 2018 Jun;28(2):269-273. doi: 10.1016/j.mycmed.2018.02.014. Epub 2018 Mar 12.
10
Diabetes mellitus as the major risk factor for mucormycosis in Mexico: Epidemiology, diagnosis, and outcomes of reported cases.
Med Mycol. 2018 Jan 1;56(1):29-43. doi: 10.1093/mmy/myx017.
Zotero 插件